Sharon Benzeno, Chief Business Development Officer at Adaptive Biotechnologies Corp (ADPT), sold 30,800 shares at $64.59 ($2.0M) on 2021-02-16, disclosed to the SEC on 2021-02-17.
Open-market sale of $2.0M ADPT by Chief Business Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.42 | 5,022 | $318K | 16.0% |
| 2 | $63.42 | 5,022 | $318K | 16.0% |
| 3 | $64.59 | 1,700 | $110K | 5.5% |
| 4 | $65.29 | 9,528 | $622K | 31.2% |
| 5 | $65.29 | 9,528 | $622K | 31.2% |
| Total | $64.64 avg | 30,800 |
| $2.0M |
| 100% |
| Filing → |
| ADPT | SELL | 2025-12-08 | $425K | — | Filing → |
| ADPT | SELL | 2025-11-24 | $20.3M | — | Filing → |
| ADPT | SELL | 2025-03-06 | $312K | — | Filing → |